- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ASP8273
Total 29 results
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma Global Development, Inc.TerminatedHealthy ParticipantsUnited States
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Raynovent Biotech Co., LtdCompletedPharmacokinetics | Hepatic ImpairmentChina
-
Guangdong Raynovent Biotech Co., LtdRecruiting
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Astellas Pharma Global Development, Inc.WithdrawnHealthy Volunteers
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
UMN Pharma Inc.Completed
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes | Chronic Kidney DiseaseSpain, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Astellas Pharma IncCompletedAdvanced Solid TumorsJapan
-
Guangdong Raynovent Biotech Co., LtdCompleted
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
-
Guangdong Raynovent Biotech Co., LtdCompletedWarfarin | Drug Drug Interaction | MidazolamChina
-
Astellas Pharma Europe B.V.CompletedNeuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)Czechia, Germany, Poland, United Kingdom
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Regeneron PharmaceuticalsActive, not recruiting
-
Guangdong Raynovent Biotech Co., LtdCompletedDrug-drug InteractionChina
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP8477 | Pharmacodynamics of ASP8477France, Belgium
-
Astellas Pharma Europe B.V.CompletedDiabetes Mellitus | Diabetic Macular EdemaUnited States
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Guangdong Raynovent Biotech Co., LtdCompletedDrug Drug InteractionChina